[S61] The 8th Symposium "Current Status of Reverse Translational Research Conducted by Hospital Pharmacists" ~Approaches and viewpoints required for drug development and fostering research~

Sun. Mar 31, 2024 1:15 PM - 3:15 PM [Room 311] Conference Center 311+312 (3F)

Organizer: Satohiro Masuda (Dept. Clin. Pharm., Himeji Dokkyo Univ.), Hiroki Itoh (Oita Univ. Hosp. Dept. Pharm.), Ryuji Ikeda (Univ. Miyazaki Hosp. Dept. Pharm.), Hirofumi Jono (Dept. Pharm., Kumamoto Univ. Hosp.)

With innovative advancements in drug development and fostering research, a variety of therapeutic drugs have recently been discovered. Although novel treatment agents that modulate the function of target molecules have been widely used in clinical settings, multiple trials and errors are often necessary due to a lack of enough clinical evidence, especially in new innovative pharmacotherapies. Therefore, clinical pharmacists are required to provide novel clinical evidence for more proper medication in medical settings.
In this symposium, we would like to provide the latest topics and their backgrounds concerning the basic and clinical research conducted by clinical pharmacists working in clinical settings. In order to consider the meaning and importance of research activities by clinical pharmacists, we discuss the current approaches and viewpoints required for drug development and fostering research conducted by hospital pharmacists, their clinical questions and issues, and Future clinical application.

+Add all to schedule

オーガナイザー挨拶：増田智先（姫路獨協大薬） (1:15 PM - 1:20 PM)

1:20 PM - 1:45 PM

[S61-1] A hospital pharmacist takes on the challenge of developing a new drug to treat lung adenocarcinoma

○Kentaro Minami¹, Ryuji Ikeda¹ (1. Dept. Pharm., Miyazaki Univ. Hosp.)

1:45 PM - 2:10 PM

[S61-2] Creation of evidence by hospital pharmacist -clinical research using machine learning for antimicrobial therapy

○Shoji Kondo^1,2 (1. Department of Pharmacy, Kumamoto University Hospital, 2. Graduate School of Pharmaceutical Sciences, Kumamoto University)

2:10 PM - 2:35 PM

[S61-3] Research on “drug discovery and development” and “drug fostering and evolution” in academia aimed at high-quality drug therapy

○Kazuaki Taguchi¹ (1. Faculty of Pharmacy, Keio Univ.)

2:35 PM - 3:00 PM

[S61-4] Development and clinical application of a dosage setting strategy for patients with renal impairment based on a bottom-up approach

○Takehito Yamamoto¹ (1. Department of Pharmacy, The University of Tokyo Hospital)

総括：池田龍二（宮崎大病院薬） (3:00 PM - 3:15 PM)